Fox Chase Cancer Center
SABCS Takeaways on HR+ eBC: Neoadjuvant Weekly Nab-Paclitaxel vs. Dose Dense Paclitaxel, ET Alone in Intermediate / High-Risk Luminal Disease, NCT in Postmenopausal Women Resistant to ET
By
Fox Chase Cancer Center
FEATURING
Jennifer Matro
By
Fox Chase Cancer Center
FEATURING
Jennifer Matro
Login to view comments.
Click here to Login
